InvestorsHub Logo
Post# of 252302
Next 10
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

Re: Whalatane post# 210696

Tuesday, 04/18/2017 5:13:01 PM

Tuesday, April 18, 2017 5:13:01 PM

Post# of 252302
GLPG:

Does Filgotnib ( GLGP ) have better efficacy then either Xeljanz or Baricitnib .. at least based on their P 2 trial data to date


My science background isn't as strong as others so my opinion may not be the best to seek here. Here are some blog posts (a little dated but relevant) from someone more knowledgeable (whose already replied smile )

https://www.ozgurogut.com/thoughts/2015/8/18/jak-inhibitors-for-rheumatoid-arthritis-follow-up

https://www.ozgurogut.com/thoughts/2015/5/15/jak-inhibitors-for-rheumatoid-arthritis

https://www.ozgurogut.com/thoughts/2015/9/27/abbvie-to-galapagos

IMO if their daily dosing is good (their Phase 2 had better efficacy BID) the key will be what the larger trials show AE wise (compared to other JAKs). I don't see a huge efficacy difference. I've been long GLPG for several years and have no position in any other company developing a JAK in RA.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.